HUTCHMED (China) Limited
HealthcareNASDAQ:HCM · NASDAQ Global Select
+$0.28 today
Vol 0.03M · Avg 0.04M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-35.15%
Period High
$19.21
Period Low
$10.63
Latest
$10.96
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cidara Therapeutics, Inc.
CDTX
$5.61B
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.29B
Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
$3.90B
Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX
$3.84B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.82B
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
$2.58B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.55B
Bausch Health Companies Inc.
NYSE:BHC
$1.89B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$1.57B
Perrigo Company plc
NYSE:PRGO
$1.52B
What is the latest HCM filing?
The latest filing shown is 6-K dated Jun 12, 2026.
How many recent filings does HCM have?
Intrinsic Alpha currently shows 20 recent filings for HCM.
Explore More
Continue the stock analysis
Jump to another research area for this company.